$355 Million is the total value of Parkman Healthcare Partners LLC's 79 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $14,826,000 | +33.3% | 121,526 | -5.4% | 4.18% | -19.0% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $14,699,000 | +36.7% | 119,778 | -2.4% | 4.14% | -16.9% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB LTD | $14,557,000 | +99.1% | 261,906 | +6.1% | 4.10% | +21.0% |
| DXCM | Buy | DEXCOM INC | $13,200,000 | +53.0% | 32,560 | +1.6% | 3.72% | -7.0% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $11,768,000 | +1328.2% | 800,000 | +300.0% | 3.32% | +767.8% |
| HUM | New | HUMANA INC | $11,633,000 | – | 30,000 | +100.0% | 3.28% | – |
| MRK | Sell | MERCK & CO. INC | $9,730,000 | -41.4% | 125,826 | -41.7% | 2.74% | -64.4% |
| DHR | New | DANAHER CORPORATION | $8,842,000 | – | 50,000 | +100.0% | 2.49% | – |
| AXNX | AXONICS MODULATION TECHNOLOG | $8,493,000 | +38.2% | 241,909 | 0.0% | 2.39% | -16.0% | |
| UNH | Sell | UNITEDHEALTH GROUP INC | $8,406,000 | -3.7% | 28,500 | -18.6% | 2.37% | -41.5% |
| XBI | New | SPDR SER TRput | $8,396,000 | – | 75,000 | +100.0% | 2.36% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $8,293,000 | – | 120,000 | +100.0% | 2.34% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $7,640,000 | +38.3% | 300,805 | 0.0% | 2.15% | -16.0% | |
| NTRA | Buy | NATERA INC | $7,486,000 | +194.5% | 150,133 | +76.4% | 2.11% | +79.0% |
| XENE | XENON PHARMACEUTICALS INC | $7,402,000 | +10.6% | 590,267 | 0.0% | 2.08% | -32.8% | |
| ABBV | New | ABBVIE INC | $7,364,000 | – | 75,000 | +100.0% | 2.08% | – |
| ICAD | ICAD INC | $7,249,000 | +36.1% | 725,590 | 0.0% | 2.04% | -17.3% | |
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $7,125,000 | +98.6% | 110,318 | +37.4% | 2.01% | +20.8% |
| CRL | New | CHARLES RIV LABS INTL INC | $6,974,000 | – | 40,000 | +100.0% | 1.96% | – |
| CTLT | New | CATALENT INC | $6,964,000 | – | 95,000 | +100.0% | 1.96% | – |
| IQV | Buy | IQVIA HLDGS INC | $6,739,000 | +108.3% | 47,500 | +58.3% | 1.90% | +26.6% |
| VCEL | Buy | VERICEL CORP | $6,569,000 | +116.9% | 475,296 | +43.9% | 1.85% | +31.8% |
| KRMD | Buy | REPRO MED SYS INC | $6,483,000 | +51.1% | 721,985 | +26.2% | 1.83% | -8.1% |
| SGEN | Buy | SEATTLE GENETICS INC | $6,372,000 | +57.3% | 37,500 | +6.8% | 1.80% | -4.4% |
| MRSN | New | MERSANA THERAPEUTICS INC | $5,850,000 | – | 250,000 | +100.0% | 1.65% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $5,806,000 | -43.0% | 20,000 | -53.3% | 1.64% | -65.4% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $5,663,000 | +182.7% | 50,000 | +66.7% | 1.60% | +71.9% |
| XLRN | Buy | ACCELERON PHARMA INC | $5,478,000 | +62.6% | 57,500 | +53.3% | 1.54% | -1.2% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $5,312,000 | +34.2% | 35,863 | -1.4% | 1.50% | -18.4% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $5,220,000 | +66.8% | 280,650 | +5.6% | 1.47% | +1.4% |
| SILK | Sell | SILK RD MED INC | $5,027,000 | +18.3% | 120,000 | -11.1% | 1.42% | -28.1% |
| MTEM | MOLECULAR TEMPLATES INC | $4,728,000 | +3.8% | 342,875 | 0.0% | 1.33% | -36.9% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $4,291,000 | +115.5% | 900,608 | -9.5% | 1.21% | +31.0% |
| RCUS | New | ARCUS BIOSCIENCES INC | $3,958,000 | – | 160,000 | +100.0% | 1.12% | – |
| KDMN | New | KADMON HLDGS INC | $3,712,000 | – | 725,000 | +100.0% | 1.05% | – |
| KOD | KODIAK SCIENCES INC | $3,530,000 | +13.5% | 65,218 | 0.0% | 0.99% | -31.1% | |
| PODD | New | INSULET CORP | $3,400,000 | – | 17,500 | +100.0% | 0.96% | – |
| NVAX | New | NOVAVAX INC | $3,334,000 | – | 40,000 | +100.0% | 0.94% | – |
| AVRO | Sell | AVROBIO INC | $3,326,000 | -27.7% | 190,593 | -35.5% | 0.94% | -56.0% |
| AXSM | New | AXSOME THERAPEUTICS INC | $3,291,000 | – | 40,000 | +100.0% | 0.93% | – |
| NUAN | Sell | NUANCE COMMUNICATIONS INC | $3,165,000 | +25.7% | 125,056 | -16.7% | 0.89% | -23.6% |
| IMVT | Buy | IMMUNOVANT INC | $3,047,000 | +387.5% | 125,125 | +211.8% | 0.86% | +195.9% |
| STXS | Buy | STEREOTAXIS INC | $2,982,000 | +51.1% | 668,693 | +2.3% | 0.84% | -8.2% |
| KALA | Buy | KALA PHARMACEUTICALS INC | $2,890,000 | +46.1% | 275,000 | +22.2% | 0.81% | -11.2% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $2,750,000 | +72.0% | 1,697,357 | +10.4% | 0.78% | +4.6% |
| HAE | Buy | HAEMONETICS CORP | $2,700,000 | +78.8% | 30,147 | +99.0% | 0.76% | +8.7% |
| SPNE | SEASPINE HLDGS CORP | $2,573,000 | +28.1% | 245,785 | 0.0% | 0.72% | -22.1% | |
| INFU | Buy | INFUSYSTEM HLDGS INC | $2,487,000 | +71.9% | 215,483 | +26.4% | 0.70% | +4.5% |
| BBIO | BRIDGEBIO PHARMA INC | $2,453,000 | +12.5% | 75,215 | 0.0% | 0.69% | -31.7% | |
| Sell | TRILLIUM THERAPEUTICS INC | $2,427,000 | +41.4% | 300,000 | -29.4% | 0.68% | -14.1% | |
| AKRO | New | AKERO THERAPEUTICS INC | $2,367,000 | – | 95,000 | +100.0% | 0.67% | – |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $2,288,000 | -44.8% | 120,802 | -44.0% | 0.64% | -66.4% |
| IRMD | Sell | IRADIMED CORP | $2,198,000 | -9.6% | 94,717 | -16.8% | 0.62% | -45.1% |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $2,117,000 | +21.3% | 130,288 | +8.3% | 0.60% | -26.3% |
| NEPH | NEPHROS INC | $2,109,000 | +33.1% | 251,366 | 0.0% | 0.59% | -19.1% | |
| ATEC | Buy | ALPHATEC HLDGS INC | $2,005,000 | +54.3% | 426,599 | +13.3% | 0.56% | -6.1% |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $1,959,000 | -50.7% | 41,085 | -49.3% | 0.55% | -70.0% |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $1,828,000 | – | 25,000 | +100.0% | 0.52% | – |
| MSON | Sell | MISONIX INC | $1,764,000 | +24.8% | 129,997 | -13.3% | 0.50% | -24.1% |
| IMUX | New | IMMUNIC INC | $1,697,000 | – | 140,000 | +100.0% | 0.48% | – |
| MGTX | Buy | MEIRAGTX HLDGS PLC | $1,690,000 | +0.6% | 135,000 | +8.0% | 0.48% | -38.9% |
| APRE | Buy | APREA THERAPEUTICS INC | $1,553,000 | +48.8% | 40,036 | +33.3% | 0.44% | -9.5% |
| PIRS | Sell | PIERIS PHARMACEUTICALS INC | $1,422,000 | +25.1% | 458,843 | -8.0% | 0.40% | -23.9% |
| SDGR | Sell | SCHRODINGER INC | $1,374,000 | -60.2% | 15,000 | -81.3% | 0.39% | -75.8% |
| QDEL | New | QUIDEL CORP | $1,342,000 | – | 6,000 | +100.0% | 0.38% | – |
| CBIO | CATALYST BIOSCIENCES INC | $1,263,000 | +34.2% | 215,237 | 0.0% | 0.36% | -18.3% | |
| RAPT | New | RAPT THERAPEUTICS INC | $1,161,000 | – | 40,000 | +100.0% | 0.33% | – |
| CATABASIS PHARMACEUTICALS IN | $1,000,000 | +55.0% | 155,473 | 0.0% | 0.28% | -5.7% | ||
| MNKD | Sell | MANNKIND CORP | $964,000 | +3.9% | 551,117 | -38.8% | 0.27% | -36.7% |
| MBIO | MUSTANG BIO INC | $965,000 | +18.7% | 303,376 | 0.0% | 0.27% | -27.9% | |
| CSTL | New | CASTLE BIOSCIENCES INC | $942,000 | – | 25,000 | +100.0% | 0.26% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $873,000 | +187.2% | 126,115 | +65.7% | 0.25% | +74.5% |
| SURF | New | SURFACE ONCOLOGY INC | $820,000 | – | 125,000 | +100.0% | 0.23% | – |
| CDMO | New | AVID BIOSERVICES INC | $821,000 | – | 125,000 | +100.0% | 0.23% | – |
| MRNA | Sell | MODERNA INC | $642,000 | -71.4% | 10,000 | -86.7% | 0.18% | -82.6% |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $445,000 | – | 30,000 | +100.0% | 0.12% | – |
| APYX | Buy | APYX MED CORP | $391,000 | +207.9% | 70,497 | +98.6% | 0.11% | +86.4% |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $254,000 | – | 100,000 | +100.0% | 0.07% | – |
| CLPT | CLEARPOINT NEURO INC | $89,000 | -1.1% | 25,078 | 0.0% | 0.02% | -40.5% | |
| FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -225,391 | -100.0% | -0.26% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -5,027 | -100.0% | -0.34% | – |
| RCM | Exit | R1 RCM INC | $0 | – | -86,492 | -100.0% | -0.36% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -50,466 | -100.0% | -0.42% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -406,383 | -100.0% | -0.50% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -20,000 | -100.0% | -0.56% | – |
| XENT | Exit | INTERSECT ENT INC | $0 | – | -165,923 | -100.0% | -0.91% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -1.00% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -9,070 | -100.0% | -2.08% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -175,453 | -100.0% | -2.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 16 | Q3 2023 | 6.3% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| XENON PHARMACEUTICALS INC | 16 | Q3 2023 | 3.3% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| AVID BIOSERVICES INC | 15 | Q3 2023 | 2.9% |
| SCHRODINGER INC | 15 | Q3 2023 | 4.2% |
| REPRO MED SYS INC | 15 | Q2 2023 | 2.0% |
| MANNKIND CORP | 15 | Q3 2023 | 1.6% |
| IQVIA HLDGS INC | 14 | Q1 2023 | 4.6% |
| INSULET CORP | 14 | Q3 2023 | 2.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.